Calidi Biotherapeutics (CLDI) Q2 2026 Earnings

14MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-6.88
-5.15
-3.41
-1.68

Details

Expected EPS
N/A
Actual EPS
-6.88
Surprise EPS
-6.88
Surprise Percent
+∞%

Description

Calidi Biotherapeutics (CLDI) has reported earnings of -6.88 per share for Q2 2026.

0 Comments

Share your thoughts